Continuous Dihydrolevoglucosenone Recovery Using Commercial Membrane Technology.

Andreas Dejaegere, Alessandro Napoli, Thomas S A Heugebaert, Christian V Stevens

Abstract read

In one paragraph

Article in Organic process research & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andreas DejaegereSynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent 9000, Belgium.

Alessandro NapoliSynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent 9000, Belgium.

Thomas S A HeugebaertSynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent 9000, Belgium.ORCID https://orcid.org/0000-0003-3297-2798

Christian V StevensSynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Ghent 9000, Belgium.ORCID https://orcid.org/0000-0003-4393-5327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyrene, or dihydrolevoglucosenone (DHL), is a biobased and biodegradable solvent that can be produced in two steps from cellulose. It has properties similar to dipolar aprotic solvents such as NMP and DMF, both of which raise significant concerns regarding environmental and human health. As such, dihydrolevoglucosenone offers a promising alternative. The use of this sustainable solvent enhances the environmental profile of chemical reactions. However, target compounds synthesized in dihydrolevoglucosenone are mainly purified using an aqueous workup, leading mostly to the disposal of DHL in an aqueous waste stream. This study focuses on recovering dihydrolevoglucosenone through back-extraction processes.

Identifiers

PMID40343116

DOI10.1021/acs.oprd.4c00494

PMCPMC12056688

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.